These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12502014)

  • 1. Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder.
    Yoshida K; Naito S; Takahashi H; Sato K; Ito K; Kamata M; Higuchi H; Shimizu T; Itoh K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K; Otani K
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1279-83. PubMed ID: 12502014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase A gene polymorphism, 5-HT 2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine.
    Yoshida K; Naito S; Takahashi H; Sato K; Ito K; Kamata M; Higuchi H; Shimizu T; Itoh K; Inoue K; Suzuki T; Ohkubo T
    Neuropsychobiology; 2003; 48(1):10-3. PubMed ID: 12886034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.
    Cusin C; Serretti A; Zanardi R; Lattuada E; Rossini D; Lilli R; Lorenzi C; Smeraldi E
    Int J Neuropsychopharmacol; 2002 Mar; 5(1):27-35. PubMed ID: 12057029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.
    Serretti A; Zanardi R; Rossini D; Cusin C; Lilli R; Smeraldi E
    Mol Psychiatry; 2001 Sep; 6(5):586-92. PubMed ID: 11526473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment.
    Takahashi H; Yoshida K; Ito K; Sato K; Kamata M; Higuchi H; Shimizu T; Ito K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):477-81. PubMed ID: 12208565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
    Serretti A; Zanardi R; Cusin C; Rossini D; Lorenzi C; Smeraldi E
    Eur Neuropsychopharmacol; 2001 Oct; 11(5):375-80. PubMed ID: 11597824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population.
    Ham BJ; Lee MS; Lee HJ; Kang RH; Han CS; Choi MJ; Lee SH; Ryu SH
    Psychiatr Genet; 2005 Dec; 15(4):299-301. PubMed ID: 16314762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population.
    Ham BJ; Lee BC; Paik JW; Kang RH; Choi MJ; Choi IG; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):104-7. PubMed ID: 16979275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine.
    Smeraldi E; Zanardi R; Benedetti F; Di Bella D; Perez J; Catalano M
    Mol Psychiatry; 1998 Nov; 3(6):508-11. PubMed ID: 9857976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of serotonin-related genes in antidepressant response.
    Peters EJ; Slager SL; McGrath PJ; Knowles JA; Hamilton SP
    Mol Psychiatry; 2004 Sep; 9(9):879-89. PubMed ID: 15052272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders.
    Kunugi H; Ishida S; Kato T; Tatsumi M; Sakai T; Hattori M; Hirose T; Nanko S
    Mol Psychiatry; 1999 Jul; 4(4):393-5. PubMed ID: 10483059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders.
    Serretti A; Cusin C; Rossini D; Artioli P; Dotoli D; Zanardi R
    Am J Med Genet B Neuropsychiatr Genet; 2004 Aug; 129B(1):36-40. PubMed ID: 15274037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.
    Sato K; Yoshida K; Takahashi H; Ito K; Kamata M; Higuchi H; Shimizu T; Itoh K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K; Otani K
    Neuropsychobiology; 2002; 46(3):136-40. PubMed ID: 12422060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine.
    Benedetti F; Dallaspezia S; Colombo C; Lorenzi C; Pirovano A; Smeraldi E
    Eur Psychiatry; 2010 Dec; 25(8):476-8. PubMed ID: 20619611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin transporter, tryptophan hydroxylase, and monoamine oxidase A gene polymorphisms in premenstrual dysphoric disorder.
    Magnay JL; Ismail KM; Chapman G; Cioni L; Jones PW; O'Brien S
    Am J Obstet Gynecol; 2006 Nov; 195(5):1254-9. PubMed ID: 17026953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan hydroxylase gene polymorphism (A218C) and suicidal behaviors.
    Tsai SJ; Hong CJ; Wang YC
    Neuroreport; 1999 Dec; 10(18):3773-5. PubMed ID: 10716208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase a and tryptophan hydroxylase gene polymorphisms: are they associated with bipolar disorder?
    Preisig M; Ferrero F; Malafosse A
    Am J Pharmacogenomics; 2005; 5(1):45-52. PubMed ID: 15727488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter.
    Furlong RA; Ho L; Rubinsztein JS; Walsh C; Paykel ES; Rubinsztein DC
    Am J Med Genet; 1999 Aug; 88(4):398-406. PubMed ID: 10402508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms.
    Serretti A; Mandelli L; Lorenzi C; Landoni S; Calati R; Insacco C; Cloninger CR
    Neuropsychobiology; 2006; 53(1):9-16. PubMed ID: 16319504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response.
    Yu YW; Tsai SJ; Hong CJ; Chen TJ; Chen MC; Yang CW
    Neuropsychopharmacology; 2005 Sep; 30(9):1719-23. PubMed ID: 15956990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.